IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ipca Laboratories Ltd. (IPCA)
The Ipca Laboratories share price today is 1,637.40, view NSE IPCA stock exchange data. Track the latest Ipca Laboratories share price with real-time updates on IPCA stock performance including market cap, day range, 52-week range and dividend yield. Access IPCA charts, earnings dates and analyst estimates to support your investment decisions.
1,639.70
-2.20(-0.13%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,610.00
1,665.00
52 wk Range
1,251.60
1,678.30
IPCA is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,610.001,665.00
52 wk Range
1,251.601,678.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.37%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.37%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
IPCA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
1,719.61
Upside
+4.87%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
- IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro - IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro - IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro - IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro - IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro - IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro - IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
15 Buy
1 Hold
1 Sell
Ratings:
17 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 1,719.61
(+4.87% Upside)
Earnings
Latest Release
29-05-2026
EPS / Forecast
11.80 / 9.33
Revenue / Forecast
23.89B / 23.68B
Compare IPCA to Peers and Sector
Metrics to compare | IPCA | Peers Peers - average of corresponding metrics from companies closely matching IPCA: ALKEM, JBCHEPHARM, MANKIND, AKUMS, ZYDUSLIFE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIPCAPeersSector |
|---|---|---|---|---|
P/E Ratio | 36.5x | 29.2x | −0.5x | |
PEG Ratio | 0.67 | 1.91 | 0.00 | |
Price/Book | 5.2x | 4.5x | 2.6x | |
Price / LTM Sales | 4.3x | 4.1x | 3.0x | |
Upside (Analyst Target) | 5.2% | 6.5% | 58.6% | |
Fair Value Upside | Unlock | 4.7% | 10.2% | Unlock |
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Ipca Laboratories (IPCA) Share Price Today?
The Ipca Laboratories share price today is 1,639.70.
What is the current Ipca Laboratories (IPCA) share price and day range?
As of 08-06-2026, the Ipca Laboratories share price is 1,639.70, with a previous close of 1,641.90. The share price has ranged from 1,610.00 to 1,665.00 today, while the 52-week range spans from 1,251.60 to 1,678.30.
What Is the Ipca Laboratories Market Cap?
As of today, Ipca Laboratories market cap is 408.46B.
Does Ipca Laboratories Pay Dividends? What's The Current Dividend Yield?
The Ipca Laboratories dividend yield is 0.37%.
What Is the Ipca Laboratories (IPCA) Share Price Target?
The average 12-month share price target for Ipca Laboratories is 1,719.61, with a high estimate of 1887 and a low estimate of 1405. 15 analysts recommend buying, while 1 suggest selling, with an overall rating of Buy and +4.87% Upside potential.
What Is Ipca Laboratories's Earnings Per Share (TTM)?
The Ipca Laboratories EPS (TTM) is 44.98.
When Is the Next Ipca Laboratories Earnings Date?
Ipca Laboratories will release its next earnings report on 17-08-2026.
From a Technical Analysis Perspective, Is IPCA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Ipca Laboratories Trade On?
Ipca Laboratories is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Ipca Laboratories?
The stock symbol for Ipca Laboratories is "IPCA."
How Many Times Has Ipca Laboratories Stock Split?
Ipca Laboratories has split 3 times.
How Many Employees Does Ipca Laboratories Have?
Ipca Laboratories has 16778 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.